Dr. Barbara Taylor, Infectious Diseases, was interviewed about the preliminary results of a clinical trial studying remdesivir as an anti-viral agent against COVID-19.
Dr. Barbara Taylor, Infectious Diseases, was interviewed about the preliminary results of a clinical trial studying remdesivir as an anti-viral agent against COVID-19.